1980American Journal of Clinical PathologyRequires access

Comparison of Enzyme Immunoassay and Latex Agglutination Methods for Detection of Cryptococcus neoformans Antigen

E. Nan Scott, H G Muchmore, Frances G. Felton

Open publisher page 35 citations

Abstract

An enzyme immunoassay for the measurement of cryptococcal capsular polysaccharide in human body fluids is described. The enzyme immunoassay detects cryptococcal capsular polysaccharide at a concentration of 6 ng/ml, compared with 35 ng/ml detectable by the latex agglutination test. The enzyme immunoassay detects cryptococcal capsular polysaccharide in body-fluid specimens that are negative by the latex agglutination test. Titers by enzyme immunoassay are generally higher and persist longer into the treatment period than those determined by latex agglutination. No cryptococcal capsular polysaccharide is detected by the enzyme immunoassay procedure in fluids from subjects not known to have cryptococcosis. The enzyme immunoassay procedure presented here provides earlier detection of cryptococcal material in body fluids, and thereby diagnosis and treatment of cryptococcosis can be made earlier in the course of disease.

About this research paper

What this paper is about

An enzyme immunoassay for the measurement of cryptococcal capsular polysaccharide in human body fluids is described. The enzyme immunoassay detects cryptococcal capsular polysaccharide at a concentration of 6 ng/ml, compared with 35 ng/ml detectable by the latex agglutination test. The enzyme immunoassay detects cryptococcal capsular polysaccharide in body-fluid specimens that are negative by the latex agglutination test. Titers by enzyme immunoassay are generally higher and persist longer into the treatment period than those determined by latex agglutination. No cryptococcal capsular polysaccharide is detected by the enzyme immunoassay procedure in fluids from subjects not known to have cryptococcosis. The enzyme immunoassay procedure presented here provides earlier detection of cryptococcal material in body fluids, and thereby diagnosis and treatment of cryptococcosis can be made earlier in the course of disease.

Why it matters

OpenAlex reports 35 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

An enzyme immunoassay for the measurement of cryptococcal capsular polysaccharide in human body fluids is described. The enzyme immunoassay detects cryptococcal capsular polysaccharide at a concentration of 6 ng/ml, compared with 35 ng/ml detectable by the latex agglutination test. The enzyme immunoassay detects cryptococcal capsular polysaccharide in body-fluid specimens that are negative by the latex agglutination test. Titers by enzyme immunoassay are generally higher and persist longer into the treatment period than those determined by latex agglutination. No cryptococcal capsular polysaccharide is detected by the enzyme immunoassay procedure in fluids from subjects not known to have cryptococcosis. The enzyme immunoassay procedure presented here provides earlier detection of cryptococcal material in body fluids, and thereby diagnosis and treatment of cryptococcosis can be made earlier in the course of disease.

Key concepts: Immunoassay, Latex fixation test, Cryptococcus neoformans, Agglutination (biology), Cryptococcosis, Microbiology, Antigen, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of Enzyme Immunoassay and Latex Agglutination Methods for Detection of Cryptococcus neoformans Antigen — Research Paper | ScholarLens